Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients
Clinical trial NCT00386373 · COMPLETED
Trial details
- NCT number
- NCT00386373
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2007-10-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.